article thumbnail

The Inflation Reduction Act Is Not Impacting Pharma R&D – Yet

Forbes: Drug Truths

Entitled "Pharmaceutical innovation and the Inflation Reduction Act: What can we learn from the first half of 2023", this policy brief examines whether "the IRA has ha.

article thumbnail

Claims that AI will “revolutionise pharma R&D” are (almost entirely) hype

DrugBaron

This month’s announcement that Alphabet’s Isomorphic Labs, led by the talented and charismatic Deepmind co-founder Demis Hassabis, had inked discovery collaboration deals with both Lilly and Novartis was just the latest indication that AI-enabled pharma R&D was ready for the big time.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Building the Disease Biology Generative AI Platform for Pharma R&D

BenchSci

Earlier this month, I traveled across North America and the UK to meet our 340 team members. Every year in January, we kick off the year with our “Roadshow”, where I meet our team in person and share our accomplishments and learning from the previous year and where we are going next.

article thumbnail

Mapping the GenAI Landscape in Pharma R&D

BenchSci

Today, the pharmaceutical (pharma) industry is in the midst of a transformative era driven by the advent of Generative AI (GenAI). Although AI adoption in pharma R&D isn’t novel, its demand has surged dramatically over the past year with the introduction of ChatGPT.

article thumbnail

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

The Pharma Data

–( BUSINESS WIRE )– Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D), specifically including molecular dynamics simulations.